Informatics Institute PowerTalk Seminar Series: Clinical Informatics with Christopher D. Willey, MD, PhD

This is a past event.

Presenter: Christopher D. Willey, MD, PhD
Director UAB Kinome Core
Professor of Radiation Oncology
UAB School of Medicine

Topic: “Multi-omic Translational Approaches to Investigate Therapeutic Resistance in Glioblastoma”

Abstract: Glioblastoma (GBM) is a devastating disease with median survival after diagnosis of only 15 months despite maximal safe resection, fractionated radiation therapy and alkylating chemotherapy with temozolomide. Despite large investments in molecularly profiling these tumors through efforts such as the TCGA, there has bene limited clinical impact. While GBM demonstrates both inherent and acquired resistance to therapy, most molecular approaches have focused only on treatment naïve specimens. Therefore, recent studies have focused on longitudinal assessment of GBM. This presentation will summarize some key recent studies as well as preclinical work at UAB related to therapeutic resistance in GBM.

Learn more about the Informatics Institute PowerTalk Seminar Series

Friday, January 21 at 12:00am to 12:00am

Virtual Event

You're not going yet!

This event requires registration.

UAB is an Equal Opportunity/Affirmative Action Employer committed to fostering a diverse, equitable and family-friendly environment in which all faculty and staff can excel and achieve work/life balance irrespective of race, national origin, age, genetic or family medical history, gender, faith, gender identity and expression as well as sexual orientation. UAB also encourages applications from individuals with disabilities and veterans.